KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Receivables - Net: 2009-2025

Historic Receivables - Net for Thermo Fisher Scientific (TMO) over the last 17 years, with Sep 2025 value amounting to $8.9 billion.

  • Thermo Fisher Scientific's Receivables - Net rose 7.95% to $8.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 billion, marking a year-over-year increase of 7.95%. This contributed to the annual value of $8.2 billion for FY2024, which is 0.36% down from last year.
  • Thermo Fisher Scientific's Receivables - Net amounted to $8.9 billion in Q3 2025, which was up 3.69% from $8.6 billion recorded in Q2 2025.
  • Thermo Fisher Scientific's 5-year Receivables - Net high stood at $8.9 billion for Q3 2025, and its period low was $5.5 billion during Q3 2021.
  • Moreover, its 3-year median value for Receivables - Net was $8.2 billion (2023), whereas its average is $8.3 billion.
  • Per our database at Business Quant, Thermo Fisher Scientific's Receivables - Net soared by 42.04% in 2022 and then dropped by 1.37% in 2024.
  • Quarterly analysis of 5 years shows Thermo Fisher Scientific's Receivables - Net stood at $8.0 billion in 2021, then increased by 1.73% to $8.1 billion in 2022, then climbed by 1.31% to $8.2 billion in 2023, then declined by 0.36% to $8.2 billion in 2024, then grew by 7.95% to $8.9 billion in 2025.
  • Its last three reported values are $8.9 billion in Q3 2025, $8.6 billion for Q2 2025, and $8.5 billion during Q1 2025.